|
WO2019156251A1
|
|
Lipopolysaccharide-regulated enteric bacteria and use thereof
|
|
EP3597183A1
|
|
Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative
|
|
EP3421041A1
|
|
Composition for preventing or treating metabolism disorders comprising leuconostoc mesenteroides-producing exopolysaccharide as active ingredient
|
|
WO2017022811A1
|
|
Emulsion composition for preventing or ameliorating snoring
|
|
EP3305756A1
|
|
Novel triglyceride and use thereof
|
|
WO2016195017A1
|
|
10-hydroxy-cis-12-octadecenoic acid alkyl ester and use thereof
|
|
US2017202890A1
|
|
Lactic acid bacterium and composition including said lactic acid bacterium
|
|
WO2015041299A1
|
|
Exopolysaccharide produced by lactic acid bacterium
|
|
WO2015020191A1
|
|
Calcium agent
|
|
CN105229142A
|
|
Immunostimulant
|
|
TW201442716A
|
|
Stable composition containing bifidobacteria
|
